Deep Diamond India Ltd (DEEPAI) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Deep Diamond India Ltd on NSE and BSE, with an AI summary of each filing.
Dear Sir/Madam, This is to inform you that, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), the Board ....
Financial Result · 04 Nov 2026, 2:49 am
Deep Health AI India Reports Q2 Results Deep Health AI India reported consolidated revenue from operations of ₹45.00 lacs for the quarter ended 30th Sep'26, down 86.57% YoY from ₹335.00 lacs. Consolidated net profit dropped 91.71% YoY to ₹20.93 lacs versus ₹252.72 lacs in the previous-year period, with basic EPS at ₹0.01 against ₹0.53. For H1 ended 30th Sep'26, consolidated revenue stood at ₹90.00 lacs, posting a net loss of ₹193.89 lacs compared to a net profit of ₹259.14 lacs YoY. Revenue was driven entirely by the pharmaceutical business segment.
Dear Sir/Madam, This is to inform you that, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), the Board ....
Outcome · 04 Nov 2026, 2:11 am
Deep Diamond India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 45.0 (-86.6% YoY | +0.0% QoQ) ■ EBITDA: 20.0 (-93.8% YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 44.4 (-5204 bps YoY | Loss to Profit QoQ) ■ PAT: 20.9 (-91.7% YoY | Loss to Profit QoQ) ■ EPS (INR): 0.01 (-98.1% YoY | Loss to Profit QoQ)
This is to inform you that, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), the Board of Directors of ....
Others (Uncategorized) · 31 Oct 2026, 1:56 am
Deep Health AI India Revises Land Acquisition Terms with Elegant Floriculture Deep Health AI India Limited approved an addendum to its MoU dated 6th Mar'26 with Elegant Floriculture & Agrotech (India) Limited for acquiring ~49,100 sq. metres of agricultural land in Pune, Maharashtra. The total acquisition consideration has been revised upward from ₹18.00 cr to ₹19.50 cr. The board acknowledged an advance payment of ₹5.625 cr already remitted by the company and approved a one-year extension for paying the balance consideration and closing the non-related-party transaction. All other terms remain unchanged.
Deep Health AI India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Dear Sir/ Madam, Pursuant ....
Intimation · 03 Nov 2026, 5:30 am
Deep Health AI India Schedules Board Meeting for Q2 Earnings Deep Health AI India Limited will hold a Board of Directors meeting on 3rd Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. Consequently, the trading window for dealing in company securities has been closed since 1st Oct'26 and will reopen 48 hours post the declaration of the financial results.
This is to inform you that, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), the Board of Directors of ....
Others (Uncategorized) · 06 Oct 2026, 12:19 am
Deep Health AI India Approves ₹10.35 Cr Debt Assignment Acquisition The Board of Deep Health AI India approved entering into a Deed of Assignment of Debt with Kshitij Polyline to acquire debt owed by Sparion Infrastructure for a consideration of ₹10,35,35,520 on 5th Oct'26. The transaction includes associated rights, claims, and underlying security featuring a pledge of 4,900 equity shares (49% equity stake) of Sparion Infrastructure. The acquisition will execute on an "as is where is", "as is what is", and "without recourse" basis. The transaction is non-related party.
This is to inform you that, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), the Board of Directors of ....
Others (Uncategorized) · 06 Oct 2026, 12:15 am
Deep Health AI India Approves ₹10.35 Cr Debt Acquisition From Kshitij Polyline Deep Health AI India Limited approved entering into a Deed of Assignment of Debt with Kshitij Polyline Limited on 5th Oct'26. The company will acquire debt due from Sparion Infrastructure Private Limited for an assignment consideration of ₹10,35,35,520. The transaction includes all associated rights, claims, and underlying security, featuring a pledge over 4,900 equity shares (49% equity stake) of Sparion Infrastructure. The acquisition will be executed on an "as is where is", "as is what is", and "without recourse" basis, with no related-party involvement.
This is to inform you that, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), the Board of Directors of ....
Outcome · 06 Oct 2026, 12:11 am
Deep Health AI India Approves ₹10.35 Crore Debt Assignment Acquisition Deep Health AI India Limited's Board approved entering into a Deed of Assignment of Debt with Kshitij Polyline Limited on 5th Oct'26. The company will acquire assigned debt owed by Sparion Infrastructure Private Limited for a consideration of ₹10,35,35,520 on an "as is where is, as is what is, and without recourse" basis. The transaction includes all associated rights, claims, and underlying security, featuring a pledge over 4,900 equity shares (49% stake) of Sparion Infrastructure. The non-related-party transaction involves no promoter group interests.
Appointment of Mr. Virendra Choubisa (DIN: 11923125) as a Non- Executive Independent Director of the Company with effect from September 03, 2026, for a term of five consecutive years, subject ....
Change in Management · 01 Oct 2026, 1:23 am
Deep Health AI India Approves Director Appointment and Auditor Transition Deep Health AI India Limited shareholders approved key management resolutions at the 32nd AGM on 30th Sep'26. The company appointed Mr. Virendra Choubisa as a Non-Executive Independent Director for a five-year term effective 3rd Sep'26 through 2nd Sep'31. Additionally, M/s Vimal C Surana & Co., Chartered Accountants, was appointed as Statutory Auditor for a five-year term (FY27 to FY32), replacing M/s VRSK & Co. LLP upon the completion of their five-year tenure.
Appointment of M/s Vimal C Surana & Co., Chartered Accountants (FRN: 015888C), as the Statutory Auditor of the Company under Section 139 of the Companies Act, 2013 and the rules made thereunder, ....
Change in Auditor · 01 Oct 2026, 1:20 am
Deep Health AI India Approves Auditor and Director Appointments at 32nd AGM Shareholders of Deep Health AI India Limited approved key appointments at the 32nd AGM held on 30th Sep'26. M/s Vimal C Surana & Co., Chartered Accountants, was appointed as Statutory Auditor for a five-year term, filling the vacancy following the tenure completion of M/s VRSK & Co. LLP. Additionally, shareholders approved the appointment of Mr. Virendra Choubisa as a Non-Executive Independent Director for a five-year term effective 3rd Sep'26 to 2nd Sep'31.
1. Appointment of Mr. Virendra Choubisa (DIN: 11923125) as a Non- Executive Independent Director of the Company with effect from September 03, 2026, for a term of five consecutive years, ....
Change in Management · 01 Oct 2026, 1:19 am
Deep Health AI India Approves Director and Statutory Auditor Appointments at AGM Deep Health AI India Limited announced that shareholders approved key management and auditor changes at its 32nd AGM on 30th Sep'26. The company approved the appointment of Virendra Choubisa as a Non-Executive Independent Director for a five-year term effective 3rd Sep'26 to 2nd Sep'31. Additionally, M/s Vimal C Surana & Co., Chartered Accountants, was appointed as Statutory Auditor for a five-year tenure spanning FY27 through the AGM in FY32, following the completion of M/s VRSK & Co. LLP's five-year term on 30th Sep'26.
Dear Sir/Madam, This is to inform you that the 32nd AGM of Deep Health AI India Limited (''the Company'') was held to say i.e. on Wednesday, September 30, 2026 at 11:30 A.M. (IST) through ....
Annual General Meeting · 01 Oct 2026, 1:13 am
Dear Sir/Madam, This is to inform you that the 32nd AGM of Deep Health AI India Limited (''the Company'') was held to say i.e. on Wednesday, September 30, 2026 at 11:30 A.M. (IST) through ....
Annual General Meeting · 01 Oct 2026, 1:08 am
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 ('Listing Regulations'), we wish to inform you that Mr. Rajesh Nandkishore Pherwani ....
Change in Management · 11 Sept 2026, 11:37 pm
Deep Health AI India Announces Independent Director Resignation Deep Health AI India Limited announced that Rajesh Nandkishore Pherwani resigned from his position as Non-Executive Independent Director, effective at the close of business hours on 11th Sep'26. Pherwani cited personal pre-occupations and the inability to devote sufficient time to company affairs as the reason for his departure, confirming there are no other material reasons. Additionally, he holds a directorship at Kshitij Polyline Limited as a Non-Executive Independent Director without board committee memberships.
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 ('Listing Regulations'), we wish to inform you that Mr. Rajesh Nandkishore Pherwani ....
Change in Management · 11 Sept 2026, 11:22 pm
Deep Health AI India Independent Director Resignation Deep Health AI India Limited announced that Non-Executive Independent Director Rajesh Nandkishore Pherwani tendered his resignation, effective from the close of business hours on 11th Sep'26. The resignation cited personal pre-occupations and an inability to dedicate sufficient time to the company's affairs, with no other material reasons reported. Pherwani also holds a Non-Executive Independent Directorship at Kshitij Polyline Limited.
Pursuant to Regulation 36(1)(b) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, the Company has sent a letter to those Members whose email addresses are not ....
Annual Report · 08 Sept 2026, 8:42 pm
We forward herewith Annual Report of the Company prepared for the Financial Year ended 2026. Annual Report is also available on the website of the Company at https://deephealthaiindia.com/reports/
Others (Uncategorized) · 08 Sept 2026, 2:44 am
We forward herewith Annual Report and Notice of the 32nd AGM of the Company scheduled to be held on Wednesday, September 30, 2026, at 11:30 A.M. via video conferencing mode which shall ....
Annual General Meeting · 08 Sept 2026, 2:37 am
This is to inform you that, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), the Board of Directors of ....
Change in Auditor · 04 Sept 2026, 3:24 am
This is to inform you that, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), the Board of Directors of ....
Change in Management · 04 Sept 2026, 3:17 am
This is to inform you that, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), the Board of Directors of ....
Others (Uncategorized) · 04 Sept 2026, 1:39 am
Deep Health AI Board Approves Key Director and Auditor Appointments Deep Health AI India approved key governance changes on 3rd Sep'26. The board proposed revising Managing Director Narayan Singh Rathore’s remuneration, pending statutory approvals. Mr. Virendra Choubisa was appointed as an Additional Non-Executive Independent Director for a five-year term. Ahead of the annual general meeting scheduled for 30th Sep'26, the board recommended M/s Vimal C Surana & Co. as the new Statutory Auditor for a five-year term, replacing M/s VRSK & Co. LLP, whose tenure formally concludes at the upcoming AGM.
Unaudited Financial Results for the quarter ended June 30, 2026.
Financial Result · 13 Aug 2026, 10:42 pm
Deep Diamond India Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakh) ■ Revenue: 45.0 (+200.0% YoY | +80.0% QoQ) ■ EBITDA: -206 (-3855.6% YoY | Profit to Loss QoQ) ■ EBITDA Margin (%): -457 (-42242 bps YoY | Profit to Loss QoQ) ■ PAT: -215 (Profit to Loss YoY | +52.3% QoQ) ■ EPS (INR): -0.15 (Profit to Loss YoY | +68.7% QoQ) Deep Diamond India Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakh) Segmental Performance Jewellery Business ■ Revenue: 0.0 ■ EBIT: 0.0 ■ EBIT Margin (%): 0.0 Pharmaceutical Business ■ Revenue: 45.0 ■ EBIT: -206 ■ EBIT Margin (%): -457
Dear Sir/Madam, This is to inform you that pursuant to Regulation 30 of the Listing Regulations, the Board at its meeting held today i.e. Thursday, August 13, 2026, inter alia, considered ....
Outcome · 13 Aug 2026, 10:28 pm
Deep Health AI Reports Net Loss of ₹2.15 cr for Q1FY27 Deep Health AI India reported a consolidated net loss of ₹214.82 lakh for the quarter ended 30 Jun'26, compared to a profit of ₹6.37 lakh YoY. Revenue from operations grew 200% YoY to ₹45.00 lakh from ₹15.00 lakh, driven entirely by the Pharmaceutical business. The company posted a loss before tax of ₹214.82 lakh versus a profit of ₹9.51 lakh YoY. Consolidated EPS stood at ₹(0.15). The pharmaceutical segment recorded an operating loss of ₹205.81 lakh for the quarter.
Deep Health AI India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Dear Sir/ Madam, Pursuant ....
Intimation · 13 Aug 2026, 5:30 am
Deep Health AI India Sets Board Meeting for Q1 FY27 Results Deep Health AI India (Scrip: 539559) will hold a Board Meeting on 13 Aug'26 to consider and approve its un-audited standalone and consolidated financial results for the quarter ended 30 Jun'26. In connection with this, the trading window for insiders has been closed since 01 Jul'26 and will reopen 48 hours after the results are declared.
This is to inform you that the 1st EGM of Deep Health AI India Limited (''the Company'') was held on Thursday, July 30, 2026, at 03:00 P.M. (IST) through Video Conferencing or Other Audio-Visual ....
Extra Ordinary General Meeting · 31 Jul 2026, 2:08 am
Deep Health AI Shareholders Approve Two New Independent Directors Deep Health AI (BSE: 539559) announced shareholders approved two special resolutions at its EGM on 30 Jul'26. The appointments of Mr. Bhupesh Swami (DIN:07999261) and Mrs. Shashi Kala Dhabriya (DIN:11611776) as Non-Executive Independent Directors were passed with a 99.85% majority for each resolution. A total of 720,066 votes were polled for each item, representing approximately 0.50% of the company's total outstanding shares. The voting was conducted via remote e-voting and e-voting during the virtual meeting.
Pursuant to Regulation 30 read with Para A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 (Listing Regulations), we wish to inform you that ....
Change in Management · 31 Jul 2026, 1:25 am
Deep Health AI Appoints Two Independent Directors to its Board Deep Health AI India announced the appointment of two Non-Executive Independent Directors, approved by shareholders on 30 Jul'26. Mr. Bhupesh Swami joins for a two-year term from 02 Jul'26 to 01 Jul'28, bringing over 20 years of experience in logistics and international trade. Mrs. Shashi Kala Dhabriya joins for a five-year term, effective from 20 Mar'26 to 19 Mar'31. Both appointees are confirmed to have no inter-se relationships with other directors, strengthening board independence and corporate governance.